ChemPartner PharmaTech Co

ChemPartner PharmaTech Co P/B

The P/B (Price-to-Book Ratio) of ChemPartner PharmaTech Co (300149.SZ) as of Oct 27, 2026 is 4.47. In the previous year, P/B (Price-to-Book Ratio) was 4.70 — a change of -4.87% (lower).

P/B

4.47

YoY

-4.87%

Last updated:

P/B (Price-to-Book Ratio) of ChemPartner PharmaTech Co is 2025 4.47 . P/B (Price-to-Book Ratio) of ChemPartner PharmaTech Co was 2024 4.70 . It decreases by -4.87% lower compared to the previous year.

The ChemPartner PharmaTech Co P/B history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/B
Date
P/B
Jan 1, 2018
2.60 CNY
Jan 1, 2019
2.49 CNY
Jan 1, 2020
2.35 CNY
Jan 1, 2021
2.90 CNY
Jan 1, 2022
2.41 CNY
Jan 1, 2023
3.97 CNY
Jan 1, 2024
4.70 CNY
Jan 1, 2025
4.47 CNY
The ChemPartner PharmaTech Co P/B history
YEARP/BYoY
4.47-4.87%
4.70+18.35%
3.97+64.38%
2.41-16.81%
2.90+23.59%
2.35-5.60%
2.49-4.44%
2.60-62.94%
7.02-5.14%
7.40-5.99%
7.88-6.70%
8.44—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

ChemPartner PharmaTech Co Stock analysis

What does ChemPartner PharmaTech Co do? ChemPartner PharmaTech Co., Ltd. generates revenue through the research, development, production, and sale of prebiotic products, primarily fructooligosaccharides and galactooligosaccharides. The company markets its products under the brand names FOS and GOS, targeting the nutrition and health, dairy, beverage, bakery, and functional snack food industries. Domestic distribution dominates, with South China as the core market, serving manufacturers of food and health products. The firm's product portfolio focuses on fructooligosaccharides and galactooligosaccharides, sold as FOS and GOS, which are integrated into various consumer goods. These prebiotics are essential ingredients in dairy, beverages, baked goods, and functional snacks, meeting demand from food producers seeking health-enhancing additives. South China remains the primary sales region, aligning with the company's domestic market strategy. ChemPartner PharmaTech's revenue streams derive from B2B sales to food and beverage manufacturers, particularly those producing nutrition and health products, dairy, and functional snacks. The company's brands FOS and GOS are positioned as key ingredients for health-focused consumer goods, with sales concentrated in South China, the main market for its domestic distribution network. ChemPartner PharmaTech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ChemPartner PharmaTech Co stock

P/B (Price-to-Book Ratio) of ChemPartner PharmaTech Co is 4.47 in 2025.

P/B (Price-to-Book Ratio) of ChemPartner PharmaTech Co changed from 4.70 to 4.47, representing a -4.87% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) ChemPartner PharmaTech Co since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s ChemPartner PharmaTech Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — ChemPartner PharmaTech Co

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — ChemPartner PharmaTech Co